Application of Nano Drugs in Treatment of Leishmaniasis
<p><strong>Objective:</strong> Leishmaniasis is endemic in 88 countries with incidence rate of 1.5-2 million; the most common form of leishmaniasis is cutaneous leishmaniasis (CL) with 1.5 million new cases per year. Correct diagnosis and characterization of the particular parasite...
Zapisane w:
Główni autorzy: | Seyed Hossein Shahcheraghi (Autor), Jamshid Ayatollahi (Autor), Marzieh Lotfi (Autor), Ali Fattahi Bafghi (Autor), Seyed Hossein Khaleghinejad (Autor) |
---|---|
Format: | Książka |
Wydane: |
Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications,
2016-08-19.
|
Hasła przedmiotowe: | |
Dostęp online: | Connect to this object online. |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy
-
Epidemiological Study an Outbreak of Cutaneous Leishmaniasis in Five Endemic Foci, Yazd Province, March 2015-March 2016.
od: Mohammad Hassan Lotfi, i wsp.
Wydane: (2017) -
Current Applications of Plant-Based Drug Delivery Nano Systems for Leishmaniasis Treatment
od: Darline B. dos Santos, i wsp.
Wydane: (2022) -
Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (SinaAmpholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
od: Seyed Ebrahim Eskandari, i wsp.
Wydane: (2018) -
Epidemiological Pattern of Cutaneous Leishmaniasis in the Province of Fars, Iran (Since 2010-2014)
od: Ali Fattahi Bafghi, i wsp.
Wydane: (2016) -
Isolation and Molecular Identification of Leishmania spp. in Patients With Cutaneous Leishmaniasis in Golestan Province, Iran
od: Ali Fattahi Bafghi, i wsp.
Wydane: (2019)